Pelvic Inflammatory Disease
📧 Sign up to get email alerts when something new happens for Pelvic Inflammatory Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II [NA]
The Technology Based Community Health Nursing (TECH-N) study, sponsored by Johns Hopkins University, is active but not recruiting and aims t…
-
FDA approval · 2025-02-14FDA Approved: METRONIDAZOLE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for metronidazole from Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2025-01-03Clinical Trial Update: The Diagnostic Utility of Ultrasound in Pelvic Inflammatory Disease (PID)
This clinical trial update reports on the diagnostic utility of ultrasound for Pelvic Inflammatory Disease, with the study currently active …
-
FDA approval · 2024-12-17FDA Approved: METRONIDAZOLE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Metronidazole from Sun Pharmaceutical Industries, Inc., resulting in continued approval of this …
-
FDA approval · 2024-10-25FDA Approved: METRONIDAZOLE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for metronidazole from Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals Inc. under an ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-06-13FDA Approved: ERTAPENEM — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for Ertapenem (ERTAPENEM) by Eugia US LLC. The action relates to a modification/expansion of the dru…
-
FDA approval · 2024-05-01FDA Approved: AMOXICILLIN AND CLAVULANATE POTASSIUM — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for Amoxicillin and clavulanate potassium (amoxicillin-clavulanate) from Northstar RxLLC, authorizin…
-
FDA label_change · 2023-11-22FDA Approved: METRONIDAZOLE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for metronidazole from Prasco Laboratories, indicating an updated labeling/approval for an additiona…
-
FDA approval · 2023-04-21FDA Approved: METRONIDAZOLE — Original Application (Viona Pharmaceuticals Inc)
The FDA approved Viona Pharmaceuticals' original application for metronidazole, granting a generic version of the antibiotic/antiprotozoal.
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases [Phase 2]
Phase 2 trial evaluating efficacy and safety of Fuke Qianjin Capsule in pelvic inflammatory disease has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease [Phase 2]
Phase 2 trial evaluating Jincaopian Tablets for chronic pelvic pain following pelvic inflammatory disease has completed.
-
FDA approval · 2022-03-16FDA Approved: METRONIDAZOLE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for METRONIDAZOLE submitted by Prasco Laboratories.
-
FDA approval · 2022-02-08FDA Approved: ERTAPENEM — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for Apotex Corp to market ertapenem sodium (ERTAPENEM) as a generic antibiotic.
-
FDA approval · 2021-08-19FDA Approved: METRONIDAZOLE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for METRONIDAZOLE submitted by Unichem Pharmaceuticals (USA), Inc., signaling an approved change…
-
FDA approval · 2021-03-05FDA Approved: METRONIDAZOLE — Supplemental Application (Baxter Healthcare Corporation)
The FDA approved a supplemental application for Metronidazole submitted by Baxter Healthcare Corporation.
-
FDA approval · 2020-09-09FDA Approved: CEFTRIAXONE AND DEXTROSE — Supplemental Application (B. Braun Medical Inc.)
FDA approved a supplemental application for Ceftriaxone and Dextrose from B. Braun Medical, resulting in an updated/expanded approval for th…
-
FDA approval · 2020-08-03FDA Approved: METRONIDAZOLE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic metronidazole (ANDA 212435), enabling a generic version of metronidazole for its establi…
-
FDA approval · 2020-05-01FDA Approved: AZITHROMYCIN — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for AZITHROMYCIN from Lupin Pharmaceuticals, Inc., signaling an update to the product's regulatory a…
-
FDA approval · 2020-05-01FDA Approved: AZITHROMYCIN DIHYDRATE — Supplemental Application (Precision Dose, Inc.)
FDA approved a supplemental application for azithromycin dihydrate submitted by Precision Dose, Inc.
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: A Clinical Study on Qianjin Capsule of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Damp-heat Stasis and Qi Deficiency Syndrome) [Phase 4]
Phase 4 clinical study evaluating Qianjin Capsule combined with antibiotics for pelvic inflammatory diseases.
-
FDA approval · 2019-07-29FDA Approved: METRONIDAZOLE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Metronidazole from Aurobindo Pharma Limited, updating an existing generic product approval.
-
CLINICAL_TRIALS trial_result · 2019-07-29Clinical Trial Update: A Clinical Study on Kangfu Anti-inflammatory Suppository of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Evidence of Dampness and Heat Accumulation) [Phase 4]
Phase 4 clinical study evaluating Kangfu anti-inflammatory suppository combined with antibiotics for pelvic inflammatory diseases.
-
FDA approval · 2018-06-25FDA Approved: ERTAPENEM — Original Application (Eugia US LLC)
The FDA approved an original application for ertapenem from Eugia US LLC, authorizing a generic version of the carbapenem antibiotic ertapen…
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Technology Enhanced Community Health Nursing (TECH-N) Study [NA]
A completed clinical trial (TECH-N study) sponsored by Johns Hopkins University focused on Pelvic Inflammatory Disease; results were posted …
-
CLINICAL_TRIALS trial_result · 2018-01-05Clinical Trial Update: A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease [Phase 4]
A Phase 4 clinical trial evaluating the efficacy and safety of Morinidazole in women with pelvic inflammatory disease is underway, with stat…